Skip to main content
Log in

Inhibition of Lipopolysaccharide-Induced Interleukin 8 in Human Adenocarcinoma Cell Line HT-29 by Spore Probiotics: B. coagulans and B. subtilis (natto)

  • Published:
Probiotics and Antimicrobial Proteins Aims and scope Submit manuscript

Abstract

Probiotics are used as a treatment for different intestinal disorders. They confer health benefits by different ways. This study was aimed to investigate immunomodulatory effect of Bacillus probiotic spores on the production of lipopolysaccharide (LPS)-induced interleukin 8 (IL-8) in HT-29 intestinal epithelial cells. Differentiated intestinal epithelial cell line was used as a model for the study of colonization of purified spores (Bacillus subtilis (natto) and B. coagulans) and their anti-inflammatory effects. MTT assay and trypan blue staining were used for the detection of optimal concentration of the purified spores and LPS. Pre-treatment assay was done by treatment of the cells with the purified spores for 2 h, followed by challenges with LPS for 3 and 18 h. Post-treatment assay was done by initial treatment of the cells with LPS for 18 h, followed by the spores for 3 and 6 h. Levels of IL-8 secretion and its mRNA expression were measured by ELISA and relative Q real-time PCR. Our results showed similar rates of adherence to intestinal epithelial cells by the spore probiotics, while displaying no cytotoxic effect. In the pre-treatment assay, a significant decrease in IL-8, at both protein and mRNA levels, was measured for B. coagulans spores after the addition of LPS, which was higher than those observed for Bacillus subtilis (natto) spores. In the post-treatment assay, while Bacillus subtilis (but not B. coagulans) diminished the LPS-stimulated IL-8 levels after 3 h of incubation, the inhibitory effect was not constant. In conclusion, ability of Bacillus spore probiotics for adherence to intestinal epithelial cell and their anti-inflammatory effects, through interference with LPS/IL-8 signaling, was shown in this study. Further studies are needed to characterize responsible bacterial compounds associated with these effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Alebouyeh M, Behzadian-Nejad Q, Soleimani M, Hassan ZM, Salmanian AH, Zali MR (2009) Characterization of the interaction of undomesticated Bacillus subtilis spores with Caco-2 cell line. Ann Microbiol 59:273–277

    Article  CAS  Google Scholar 

  2. Benson KF, Redman KA, Carter SG, Keller D, Farmer S, Endres JR, Jensen GS (2012) Probiotic metabolites from Bacillus coagulans GanedenBC30TM support maturation of antigen-presenting cells in vitro. WJG 18:1875

    Article  CAS  Google Scholar 

  3. Blaut M, Clavel T (2007) Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137:751S–755S

    CAS  Google Scholar 

  4. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker H-C, Podolsky DK (2000) Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing toll-like receptors. J Immunol 164:966–972

    Article  CAS  Google Scholar 

  5. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274:10689–10692

    Article  CAS  Google Scholar 

  6. Ciprandi G, Vizzaccaro A, Cirillo I, Tosca MA (2005) Bacillus clausii exerts immuno-modulatory activity in allergic subjects: a pilot study. Eur Ann Allergy Clin Immunol 37:129–134

    Google Scholar 

  7. de Souza RD, Batista MT, Luiz WB, Cavalcante RCM, Amorim JH, Bizerra RSP, Martins EG, de Souza Ferreira LC (2014) Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action. PLoS ONE 9:e87454

    Article  Google Scholar 

  8. Duc LH, Hong HA, Fairweather N, Ricca E, Cutting SM (2003) Bacterial spores as vaccine vehicles. Infect Immun 71:2810–2818

    Article  CAS  Google Scholar 

  9. Endres J, Clewell A, Jade K, Farber T, Hauswirth J, Schauss A (2009) Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient. Food Chem Toxicol 47:1231–1238

    Article  CAS  Google Scholar 

  10. Faille C, Jullien C, Fontaine F, Bellon-Fontaine M-N, Slomianny C, Benezech T (2002) Adhesion of Bacillus spores and Escherichia coli cells to inert surfaces: role of surface hydrophobicity. Can J Microbiol 48:728–738

    Article  CAS  Google Scholar 

  11. Fedorak RN, Madsen KL (2004) Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 10:286–299

    Article  Google Scholar 

  12. Finamore A, Roselli M, Imbinto A, Seeboth J, Oswald IP, Mengheri E (2014) Lactobacillus amylovorus inhibits the TLR4 inflammatory signaling triggered by enterotoxigenic Escherichia coli via modulation of the negative regulators and involvement of TLR2 in intestinal Caco-2 cells and pig explants. PLoS ONE 9:e94891

    Article  Google Scholar 

  13. Foligné B, Peys E, Vandenkerckhove J, Dewulf J, Breton J, Pot B (2012) Spores from two distinct colony types of the strain Bacillus subtilis PB6 substantiate anti-inflammatory probiotic effects in mice. Clin Nutr 31:987–994

    Article  Google Scholar 

  14. Food and Agriculture Organisation, and World Health Organization (2006) Probiotics in food: health and nutritional properties and guidelines for evaluation. FAO, Rome

    Google Scholar 

  15. Haddad JJ, Abdel-Karim NE (2011) NF-κB cellular and molecular regulatory mechanisms and pathways: therapeutic pattern or pseudoregulation? Cell Immunol 271:5–14

    Article  CAS  Google Scholar 

  16. Hardy H, Harris J, Lyon E, Beal J, Foey AD (2013) Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5:1869–1912

    Article  CAS  Google Scholar 

  17. Hong HA, Cutting SM (2005) The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29:813–835

    Article  CAS  Google Scholar 

  18. Hong HA, Duc LH, Cutting SM (2005) The use of bacterial spore formers as probiotics. FEMS Microbiol Rev 29:813–835

    Article  CAS  Google Scholar 

  19. Hosoi T, Hirose R, Saegusa S, Ametani A, Kiuchi K, Kaminogawa S (2003) Cytokine responses of human intestinal epithelial-like Caco-2 cells to the nonpathogenic bacterium Bacillus subtilis (natto). Int J Food Microbiol 82:255–264

    Article  CAS  Google Scholar 

  20. Isolauri E, Kirjavainen P, Salminen S (2002) Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 50:iii54–iii59

    Article  Google Scholar 

  21. Joshi LT, Phillips DS, Williams CF, Alyousef A, Baillie L (2012) Contribution of spores to the ability of Clostridium difficile to adhere to surfaces. Appl Environ Microbiol 78:7671–7679

    Article  CAS  Google Scholar 

  22. Kirjavainen P, Mattila-Sandholm T, Saarela M (2003) Probiotics and the management of food allergy. In: Functional dairy products. Woodhead Publishing Limited, pp 108–131

  23. Kozuka S, Tochikubo K (1985) Properties and origin of filamentous appendages on spores of Bacillus cereus. Microbiol Immunol 29:21–37

    Article  CAS  Google Scholar 

  24. La Ragione RM, Woodward MJ (2003) Competitive exclusion by Bacillus subtilis spores of salmonella enterica serotype enteritidis and clostridium perfringens in young chickens. Vet Microbiol 94:245–256

    Article  Google Scholar 

  25. La Ragione RM, Casula G, Cutting SM, Woodward MJ (2001) Bacillus subtilis spores competitively exclude Escherichia coli O78: K80 in poultry. Vet Microbiol 79:133–142

    Article  Google Scholar 

  26. Lenoir-Wijnkoop I, Sanders ME, Cabana MD, Caglar E, Corthier G, Rayes N, Sherman PM, Timmerman HM, Vaneechoutte M, Van Loo J (2007) Probiotic and prebiotic influence beyond the intestinal tract. Nutr Rev 65:469–489

    Article  Google Scholar 

  27. Long KZ, Rosado JL, Santos JI, Haas M, Al Mamun A, DuPont HL, Nanthakumar NN, Estrada-Garcia T (2010) Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections. Infect Immun 78:1221–1228

    Article  CAS  Google Scholar 

  28. Martínez-Maqueda D, Miralles B, Recio I (2015) HT29 cell line. In: The impact of food bioactives on health. Springer, Berlin, pp 113–124

  29. Medvedev A, Kopydlowski K, Vogel S (2000) Expression chemokine, and toll-like receptor 2 and 4 gene macrophages: deregulation of cytokine, transduction in endotoxin-tolerated mouse inhibition of lipopolysaccharide-induced signal. J Immunol 164:5564–5574

    Article  CAS  Google Scholar 

  30. Moré MI, Swidsinski A (2015) Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis: a review. Clin Exp Gastroenterol 11:237

    Article  Google Scholar 

  31. Moue M, Tohno M, Shimazu T, Kido T, Aso H, Saito T, Kitazawa H (2008) Toll-like receptor 4 and cytokine expression involved in functional immune response in an originally established porcine intestinal epitheliocyte cell line. BBA 1780:134–144

    CAS  Google Scholar 

  32. O’Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in toll-like receptor signalling. Nat Rev Immunol 7:353–364

    Article  Google Scholar 

  33. O’Sullivan G, Kelly P, O’Halloran S, Collins C, Collins J, Dunne C, Shanahan F (2005) Probiotics: an emerging therapy. Curr Pharmaceut Des 11:3–10

    Article  Google Scholar 

  34. Pesce G, Rusciano G, Sasso A, Isticato R, Sirec T, Ricca E (2014) Surface charge and hydrodynamic coefficient measurements of Bacillus subtilis spore by optical tweezers. Biointerfaces 116:568–575

    Article  CAS  Google Scholar 

  35. Sabet M, Cottam HB, Guiney DG (2006) Modulation of cytokine production and enhancement of cell viability by TLR7 and TLR9 ligands during anthrax infection of macrophages. FEMS Immunol Med Microbiol 47:369–379

    Article  CAS  Google Scholar 

  36. Sánchez B, Arias S, Chaignepain S, Denayrolles M, Schmitter J, Bressollier P, Urdaci M (2009) Identification of surface proteins involved in the adhesion of a probiotic Bacillus cereus strain to mucin and fibronectin. Microbiology 155:1708–1716

    Article  Google Scholar 

  37. Sudha RM, Sunita M, Sekhar BM (2011) Safety studies of Bacillus coagulans unique IS-2 in rats: morphological, biochemical and clinical evaluations. Int J Probiotics Prebiotics 6:43–48

    Google Scholar 

  38. Taverniti V, Guglielmetti S (2011) The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr 6:261–274

    Article  Google Scholar 

  39. Tekin IO, Oral HB, Shiri-Sverdlov R (2015) Mediators of gut mucosal immunity and inflammation. Mediat Inflamm 2015:765303

    Article  Google Scholar 

  40. Wheeler DS, Chase MA, Senft AP, Poynter SE, Wong HR, Page K (2009) Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via toll-like receptor (TLR)-4. Resp Res 10:1

    Article  Google Scholar 

  41. Zeytun A, Chaudhary A, Pardington P, Cary RB, Gupta G (2010) Induction of cytokines and chemokines by toll-like receptor signaling: strategies for control of infammation. Crit Rev Immunol 30(1):53–67

    Article  CAS  Google Scholar 

  42. Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS (2005) Differential induction of the toll-like receptor 4-MyD88-dependent and-independent signaling pathways by endotoxins. Infect Immun 73:2940–2950

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We are grateful to Dr. Mojtaba Jafari, for the preparation of Bacillus probiotics strains. This study was a part of MSc thesis that was supported by Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masoud Alebouyeh.

Ethics declarations

Conflict of interest

Azimirad Masoumeh, Alebouyeh Masoud, and Naji Tahereh declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Fig. 1

RT-PCR for quality control of RNA extraction and cDNA synthesis. M: DNA Ladder mix; Lanes 1–10: PCR products for the prepared cDNAs from the pre- and post-treated cells. Lane 11: negative control (DOCX 67 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Azimirad, M., Alebouyeh, M. & Naji, T. Inhibition of Lipopolysaccharide-Induced Interleukin 8 in Human Adenocarcinoma Cell Line HT-29 by Spore Probiotics: B. coagulans and B. subtilis (natto). Probiotics & Antimicro. Prot. 9, 56–63 (2017). https://doi.org/10.1007/s12602-016-9234-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12602-016-9234-x

Keywords

Navigation